Actively Recruiting
Phase IIb Study of AZD5148 to Prevent Recurrence of Clostridioides Difficile Infection in Adults 18 and Over
Led by AstraZeneca · Updated on 2026-10-07
230
Participants Needed
117
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the prevention of recurrent Clostridioides difficile infection CDI in adults aged 18 and older. This Phase IIb clinical trial evaluates the safety and effectiveness of a drug called AZD5148 compared to a placebo. The trial is randomized, double-blind, and placebo-controlled, aiming to reduce the chance of CDI coming back. This study is sponsored by AstraZeneca and focuses on preventing infection recurrence in participants who have recently experienced CDI and are undergoing antibacterial treatment. Participants will be randomly assigned to receive a single dose of either AZD5148 or a placebo, given by either intramuscular injection or intravenous push as decided by the investigator. The treatment is administered once during the antibacterial therapy, which must last between 10 and 28 days. The study involves up to two visits for eligibility confirmation and dosing, followed by up to seven planned visits for monitoring. Participants will also complete an electronic diary and receive follow-up contacts weekly at first, then monthly. Participants will be closely monitored through stool sample collections, symptom tracking, and assessment of any adverse events. Researchers will evaluate the first recurrence of CDI within 91 days, duration and severity of diarrhea symptoms, hospitalizations related to CDI, and any adverse reactions to the study drug. Safety assessments continue for up to 361 days after dosing, including analysis of drug levels and immune responses. The total participation time may extend over a year to fully assess outcomes and safety.
CONDITIONS
Brief Title
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Research Team
A
AstraZeneca Clinical Study Information Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here